Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Enjoy this offer
* See conditions under "Our services"

Valuation: Becton, Dickinson and Company

Market Cap 4.07TCr 3.52TCr 3.25TCr 3.04TCr 5.67TCr 3,88000Cr 5.8TCr 39TCr 15TCr 1,87900Cr 15TCr 15TCr 6,53400Cr P/E ratio 2026 *
36.8x
P/E ratio 2027 * 28.2x
Enterprise value 5.67TCr 4.91TCr 4.52TCr 4.23TCr 7.89TCr 5,40000Cr 8.07TCr 54TCr 21TCr 2,61500Cr 21TCr 21TCr 9,09400Cr EV / Sales 2026 *
2.95x
EV / Sales 2027 * 2.78x
Free-Float
74.04%
Yield 2026 *
2.61%
Yield 2027 * 2.66%
1 day-2.80%
1 week+1.50%
Current month+0.46%
1 month-1.10%
3 months-9.82%
6 months-25.51%
Current year-23.85%
1 week 147.74
Extreme 147.74
153.24
1 month 141.82
Extreme 141.8201
153.24
Current year 141.82
Extreme 141.8201
213.08
1 year 141.82
Extreme 141.8201
213.08
3 years 141.82
Extreme 141.8201
287.32
5 years 141.82
Extreme 141.8201
287.32
10 years 141.82
Extreme 141.8201
287.32
Manager TitleAgeSince
Chief Executive Officer 53 28/01/2020
Director of Finance/CFO 44 05/12/2025
Compliance Officer - 01/02/2023
Director TitleAgeSince
Director/Board Member 75 24/09/2002
Director/Board Member 71 26/07/2010
Chairman 53 28/04/2021
Date Insider Type Main position Quantity % Market Cap.
01/06Fiscal year

Chief Executive Officer

60,627 0.0220%
01/06Free

Executive/Senior Manager

14,258 0.0052%
01/06Other

Executive/Senior Manager

0 0%
Change 5-day change 1-year change 3-year change Capi.($)
-2.80%+1.50%-15.25%-41.24% 4.19TCr
-2.28%+2.51%-33.52%-12.31% 16TCr
-2.11%+2.95%-8.77%-4.16% 11TCr
+0.60%+6.68%-1.06%+57.80% 5.44TCr
-0.51%-3.29%+49.21%+46.60% 5.35TCr
-4.37%+2.75%-11.85%-39.87% 3.02TCr
+1.47%+6.01% - - 3.05TCr
-1.12%+4.62%+45.33%-4.98% 2.36TCr
-1.86%-0.72%-14.75%+1.19% 2.1TCr
-2.25%-0.99%-14.14%+0.54% 2.08TCr
Average -1.56%+2.64%-0.53%+0.40% 5.4TCr
Weighted average by Cap. -1.68%+2.56%-8.25%+0.45%

Financials

2026 *2027 *
Net sales 1.92TCr 1.66TCr 1.53TCr 1.43TCr 2.68TCr 1,83000Cr 2.74TCr 18TCr 7.06TCr 89TCr 7.21TCr 7.05TCr 3,08100Cr 1.97TCr 1.71TCr 1.57TCr 1.47TCr 2.75TCr 1,87800Cr 2.81TCr 19TCr 7.25TCr 91TCr 7.4TCr 7.24TCr 3,16300Cr
Net income 112.46Cr 97Cr 90Cr 84Cr 156.65Cr 11TCr 160.17Cr 1.07TCr 413.45Cr 5.19TCr 422.17Cr 413.1Cr 18TCr 146.16Cr 126.5Cr 116.62Cr 109.1Cr 203.58Cr 14TCr 208.16Cr 1.39TCr 537.33Cr 6.74TCr 548.65Cr 536.87Cr 23TCr
Net Debt 1.6TCr 1.38TCr 1.27TCr 1.19TCr 2.22TCr 1,52000Cr 2.27TCr 15TCr 5.87TCr 74TCr 5.99TCr 5.86TCr 2,56000Cr 1.41TCr 1.22TCr 1.12TCr 1.05TCr 1.96TCr 1,34100Cr 2TCr 13TCr 5.17TCr 65TCr 5.28TCr 5.17TCr 2,25800Cr
Logo Becton, Dickinson and Company
Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical management systems (52.4%): medication delivery systems, pharmaceutical systems, advanced patient monitoring systems, etc.; - interventional medical equipment (23.9%): surgical instruments, urological care products, etc.; - diagnostic materials and clinical research and development tools (23.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, tools for studying genes and culturing cells, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (58.6%), Europe/Middle East/Africa (21.6%), Asia (14.2%) and other (5.6%).
Employees
72,000
Date Price Change Volume
10/26/10 147.79 $ -2.80% 17,47,849
09/26/09 152.04 $ +1.37% 22,14,895
08/26/08 149.99 $ -0.77% 19,25,969
05/26/05 151.16 $ +1.07% 20,77,544
04/26/04 149.56 $ +2.71% 22,41,684
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
147.79USD
Average target price
181.23USD
Spread / Average Target
+22.63%

Quarterly revenue - Rate of surprise

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
BENEFIT NOW